2025-12-13 - Analysis Report
Okay, here's a comprehensive analysis of Nike (NKE) based on the data you provided.

**1. Return Rate Comparison**

*   **Company Overview:** Nike Inc. is a global leader in athletic footwear, apparel, equipment, and accessories.
*   **NKE Cumulative Return:** -21.41%
*   **VOO (S&P 500) Cumulative Return:** 102.37%
*   **Divergence:** -120.4 (-127.6 to 32.5 range, relative divergence of 4.5)

**Analysis:** Nike has significantly underperformed the S&P 500 over the provided period, with a substantial negative divergence. The relative divergence of 4.5 indicates that the current divergence is near the lowest end of its historical range.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha   | Beta  | Cap(B) |
|------------|--------|-------|---------|-------|--------|
| 2015-2017  | 18.0%  | 69.2% | -11.0%  | 0.1   | 94.8   |
| 2016-2018  | 0.0%   | 10.7% | -16.0%  | -0.0  | 112.4  |
| 2017-2019  | 49.0%  | 69.4% | 27.0%   | 0.4   | 153.6  |
| 2018-2020  | 45.0%  | 81.7% | 22.0%   | 0.4   | 214.5  |
| 2019-2021  | 60.0%  | 81.7% | 13.0%   | 0.8   | 252.7  |
| 2020-2022  | -11.0% | 81.7% | -10.0%  | 1.8   | 177.4  |
| 2021-2023  | -27.0% | 80.7% | -29.0%  | 2.5   | 164.6  |
| 2022-2024  | -71.0% | 80.7% | -91.0%  | 2.4   | 114.7  |
| 2023-2025  | -56.0% | 83.6% | -123.0% | -0.7   | 99.7   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate shows a decline in recent years.
*   **MDD:** The Maximum Drawdown indicates significant risk and volatility in the stock, consistently high over the period.
*   **Alpha:** Negative Alpha in recent periods suggests Nike has underperformed its benchmark (risk-adjusted).  The negative and increasingly negative Alpha highlights this underperformance.
*   **Beta:** Beta has been volatile, recently showing higher than usual market sensitivity (Beta greater than 1) and indicates greater volatility than the overall market, although the most recent period shows a significant drop below 0, potentially indicating a contrarian performance.
*   **Cap(B):** Market Capitalization declined significantly recently, reflecting investor concerns.

**2. Recent Stock Price Fluctuations**

*   **Close:** 65.79
*   **Last Market Price:** 67.47
*   **Previous Close:** 67.74
*   **Change:** -0.4
*   **5-day SMA:** 64.84
*   **20-day SMA:** 64.07
*   **60-day SMA:** 66.61

**Analysis:** The stock price is currently below its 60-day moving average, but above the 5-day and 20-day moving averages. This suggests a possible short-term upward trend, but still below the longer-term average. The recent small price decrease may reflect mixed sentiment.

**3. RSI, PPO Index, and Divergence**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment Recommended)
*   **RSI:** 61.85
*   **PPO:** 0.465
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (25 shares - Very Safe - MRI:0.90) Dividend_0.41 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** 1.2 (+) (Short-term increase)
*   **Expected Return (%):** -734.9

**Analysis:**

*   **MRI:** A medium investment recommendation indicates moderate risk with potential for return.
*   **RSI:** An RSI of 61.85 is nearing overbought territory, suggesting a potential for a pullback.
*   **PPO:** A slightly positive PPO indicates a potential bullish trend.
*   **Hybrid Signal:** The 'Buy' signal based on MRI suggests confidence in Nike's fundamentals.
*   **Divergence Change:** The short-term increase in relative divergence suggests a potential short-term upward trend.
*   **Expected Return:** The extremely negative expected return is alarming and requires deeper investigation. This figure is suspect and could be due to an error in calculation. It suggests a high potential for loss if invested long-term.

**4. Recent News & Significant Events**

The news headlines are a mix of positive and concerning factors:

*   **Positive:** Multiple articles suggest a potential buying opportunity ahead of earnings, citing turnaround efforts and analyst optimism.
*   **Negative:** One article highlights potential challenges related to margins, China, and tariffs.
*   **Analyst Focus:** Emphasis on the upcoming earnings report (Dec 18) suggests it will be a crucial catalyst for the stock.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean = 1.93)
*   **Target Price:** 83.07 (Avg), 120.00 (High), 38.00 (Low)

**Analysis:** Analyst consensus is generally positive, with a "Buy" rating and a significant upside potential based on the average target price. However, the wide range between high and low target prices indicates uncertainty.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-10-01 | 0.49 | 11.72 B$  |
| 2025-04-03 | 0.54 | 11.27 B$  |
| 2025-01-03 | 0.78 | 12.35 B$  |
| 2024-10-07 | 0.7  | 11.59 B$  |
| 2025-10-01 | 0.7  | 11.59 B$  |

**Analysis:**

*   **EPS:** EPS has been inconsistent, with a recent drop.
*   **Revenue:** Revenue has also fluctuated, with a recent peak.
*   **Trend:** This data suggests a possible slowing of growth or challenges in maintaining profitability. The duplicate entry for "2025-10-01" needs to be verified as it can skew analysis.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-08-31   | $11.72B   | 42.18%        |
| 2025-05-31   | $11.10B   | 40.27%        |
| 2025-02-28   | $11.27B   | 41.49%        |
| 2024-11-30   | $12.35B   | 43.62%        |
| 2024-08-31   | $11.59B   | 45.36%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-08-31   | $13.47B   | 5.40%   |
| 2025-05-31   | $13.21B   | 1.60%   |
| 2025-02-28   | $14.01B   | 5.67%   |
| 2024-11-30   | $14.04B   | 8.29%   |
| 2024-08-31   | $13.94B   | 7.54%   |

**Analysis:**

*   **Revenue:** Revenue has generally fluctuated, and is currently below its recent high.
*   **Profit Margin:** Profit margins have declined recently, impacting profitability.
*   **Equity:** Equity has slightly decreased.
*   **ROE:** Return on Equity has declined significantly, indicating less efficient use of shareholder equity to generate profits.

**7. Comprehensive Analysis**

Based on the provided data, Nike (NKE) presents a mixed investment picture:

*   **Underperformance:** NKE has significantly underperformed the S&P 500.
*   **Volatility:** High Maximum Drawdown and a relatively volatile beta indicates significant risk.
*   **Financials:** Recent financial data reveals declining revenue growth, decreasing profit margins, and a drop in ROE.
*   **Market Sentiment:** Analyst consensus is generally positive, but the wide range of target prices and mixed news headlines reflect uncertainty.
*   **Technical Indicators:** RSI suggests the stock is nearing overbought conditions, while the PPO indicates a slight bullish trend.
*   **The negative Expected Return figure is alarming and requires further investigation to confirm its accuracy.**

**Overall:** Nike is undergoing a period of significant challenges. While analysts see potential for a turnaround, key financial metrics are weakening. The upcoming earnings report will be crucial to assess the effectiveness of Nike's "Win Now" strategy and its ability to overcome headwinds. Investors should carefully weigh the risks and rewards before investing.



**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.